RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 49.71
+0.30 (0.61%)
Apr 22, 2025, 1:45 PM CST
RemeGen Revenue
In the year 2024, RemeGen had annual revenue of 1.72B CNY with 58.54% growth. RemeGen had revenue of 507.99M in the quarter ending December 31, 2024, with 62.05% growth.
Revenue
1.72B
Revenue Growth
+58.54%
P/S Ratio
12.70
Revenue / Employee
572.48K
Employees
2,999
Market Cap
21.81B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |